Skip to main content

Diagnosis‐Based Cohort Augmentation using Laboratory Results Data: The Case of Chronic Kidney Disease

    Basic Details

    The authors used data from FDA's Sentinel System to focus on how augmenting a diagnosis‐based chronic kidney disease cohort with patients identified through laboratory results impacts cohort characteristics and outcomes. They suggest that drug safety researchers consider whether the method of cohort identification contributes to generalizability of safety findings.


    David Smith, Susan Shetterly, James Flory, Kevin Haynes, Christine Lu, Joshua Gagne, Lisa Herrinton, Carsie Nyirenda, Elisabetta Patorno, Azadeh Shoaibi, Marsha Raebel 

    Corresponding Author

    David Smith, Center for Health Research, Kaiser Permanente Northwest, Portland, OR, USA. Email: